CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
69
|
53 |
ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
61
|
54 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
44
|
49 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
38
|
56 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
35
|
41 |
GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
29
|
8 |
TEX41 |
|
testis expressed 41
|
|
|
0.743 |
0.269 |
22
|
32 |
HNF1A-AS1 |
|
HNF1A antisense RNA 1
|
|
|
0.621 |
0.538 |
20
|
13 |
BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
20
|
23 |
LIPC-AS1 |
|
LIPC antisense RNA 1
|
|
|
0.839 |
0.154 |
19
|
7 |
LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
19
|
24 |
ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
18
|
17 |
BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
18
|
15 |
LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
17
|
15 |
OBI1-AS1 |
|
OBI1 antisense RNA 1
|
|
|
0.792 |
0.115 |
14
|
6 |
VLDLR-AS1 |
|
VLDLR antisense RNA 1
|
|
|
0.821 |
0.115 |
14
|
11 |
CCNT2-AS1 |
|
CCNT2 antisense RNA 1
|
|
|
0.931 |
0.115 |
11
|
9 |
LINC00240 |
|
long intergenic non-protein coding RNA 240
|
|
|
0.821 |
0.231 |
11
|
10 |
TARID |
|
TCF21 antisense RNA inducing promoter demethylation
|
|
|
0.821 |
0.308 |
11
|
14 |
LINC01091 |
|
long intergenic non-protein coding RNA 1091
|
|
|
0.821 |
0.231 |
11
|
8 |
LINC01006 |
Q8NI28
|
long intergenic non-protein coding RNA 1006
|
|
|
0.780 |
0.269 |
9
|
8 |
LINC01150 |
|
long intergenic non-protein coding RNA 1150
|
|
|
0.931 |
0.038 |
9
|
2 |
HOTTIP |
|
HOXA distal transcript antisense RNA
|
|
|
0.575 |
0.654 |
8
|
9 |
LINC02398 |
|
long intergenic non-protein coding RNA 2398
|
|
|
0.931 |
0.115 |
7
|
11 |